A British government advisory committee recommended not to use the “Oxford – AstraZenica” vaccine for those under the age of thirty and to give them an alternative vaccine, amid fears of its possible link to stroke.
The Intergovernmental Committee on Vaccination and Immunization issued this new recommendation for adults between the ages of 18 and 29 who do not have underlying health problems or are not at risk from infection with the “Corona” virus, according to what was reported by the British newspaper “The Independent” today, Wednesday.
The British Medicines Regulatory Authority stated that there are 79 cases of blood clots linked to low platelet count, 19 of whom died, including three under the age of thirty.
During a joint press conference with the government committee, John Ryan, head of the British Medicines and Healthcare Products Regulatory Agency, said that these cases are out of 20 million doses that were administered, stressing that the vaccination has saved thousands of lives.
He added, “More work is needed to prove beyond a reasonable doubt that the vaccine has caused these side effects.”
Earlier, a member of the government committee said that experts need to ensure that the benefits of the vaccine outweigh the risks for younger age groups, as “the risk of serious illness and death from Covid-19 is much lower than that of middle-aged and elderly Prime Time Zone,” according to What was quoted by the newspaper.
The European Medicines Agency also announced today that there are possible links between the “AstraZeneca” vaccine and the occurrence of rare blood clots, but it reiterated that the benefits of the vaccine still outweigh the potential risks, and said it had not yet reached specific risk factors linking the vaccine to clots.
The article A British government committee recommends against using the AstraZeneca vaccine for Prime Time Zone under the age of 30.